crystalgenomics inc
CrystalGenomics Starts Phase IIb Study For Osteoarthritis
CG Pharmaceuticals, Inc. has enrolled the first patient for a Phase IIb clinical study of its novel NSAID candidate.
CG Pharmaceuticals, Inc. has enrolled the first patient for a Phase IIb clinical study of its novel NSAID candidate.
